Risperdal judgement reversed


The Arkansas Supreme Court reverses the $1.2B judgment against Johnson & Johnson (JNJ) for improperly marketing the anti-psychotic drug Risperdal.

The court overturned the state's case because it had sued under a law covering health care facilities instead of drug companies.

From other sites
Comments (6)
  • joelgwood
    , contributor
    Comments (23) | Send Message
     
    This is good news. LAWYERS were awarded $181 MILLION if this had been allowed to stand. That is just absurd. The states have identified this "medicaid fraud" method as a way to shake down pharmaceutical companies. Glad that JNJ fought this all the way to the Arkansas Supreme Court.
    20 Mar 2014, 02:45 PM Reply Like
  • jimhelond
    , contributor
    Comments (2) | Send Message
     
    Does this mean that they will sue again in the involved state ?
    20 Mar 2014, 03:22 PM Reply Like
  • jimhelond
    , contributor
    Comments (2) | Send Message
     
    Does this mean that the involved state will merely sue agin under a different law ?
    20 Mar 2014, 03:22 PM Reply Like
  • chillen22
    , contributor
    Comments (43) | Send Message
     
    i dont think they can. Would that not be double jeopardy
    20 Mar 2014, 04:53 PM Reply Like
  • jumpnjoey77
    , contributor
    Comments (1195) | Send Message
     
    Got to love technicalities.
    20 Mar 2014, 03:48 PM Reply Like
  • joelgwood
    , contributor
    Comments (23) | Send Message
     
    According the AR Attorney General, they can only refile the part of the suit in which JNJ was fined $11 MILLION for "deceptive trade practices". Big win for JNJ!!!
    20 Mar 2014, 05:10 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs